| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
111.8 |
mmHg |
3.9 |
17.87 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69527 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
160.2 |
mmHg |
3.5 |
12.62 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69534 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (100 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
147.2 |
mmHg |
3.9 |
14.06 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69532 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
128.6 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69537 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
20 |
serial mean |
135.6 |
mmHg |
3.2 |
14.31 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69539 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
16 |
serial mean |
118.6 |
mmHg |
3.4 |
13.6 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69543 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
138.6 |
mmHg |
3.8 |
17.41 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69547 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
serial mean |
159.1 |
mmHg |
6.4 |
19.2 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69550 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89.0 days-92.0 days |
21 |
serial mean |
174.0 |
mmHg |
6.0 |
27.5 |
vascular indwelling catheter method |
left femoral artery |
|
|
3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day |
11854 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (100 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
132.9 |
mmHg |
3.8 |
17.41 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69531 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
120.4 |
mmHg |
5.3 |
24.29 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69535 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
serial mean |
160.0 |
mmHg |
6.7 |
20.1 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69548 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89.0 days-91.0 days |
20 |
serial mean |
111.0 |
mmHg |
2.7 |
12.07 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
69447 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
14 |
serial mean |
89.0 |
mmHg |
2.0 |
7.48 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
65466 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89.0 days-92.0 days |
21 |
serial mean |
110.0 |
mmHg |
3.0 |
13.75 |
vascular indwelling catheter method |
left femoral artery |
|
|
3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day |
11853 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
139.1 |
mmHg |
3.6 |
16.5 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69533 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
serial mean |
132.0 |
mmHg |
7.0 |
21.0 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69542 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
159.0 |
mmHg |
6.4 |
23.08 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69538 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
17 |
serial mean |
144.9 |
mmHg |
3.1 |
12.78 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69549 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
12 |
serial mean |
142.0 |
mmHg |
5.0 |
17.32 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
65467 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89.0 days-91.0 days |
15 |
serial mean |
159.0 |
mmHg |
6.0 |
23.24 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
69448 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (20 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
131.3 |
mmHg |
4.2 |
15.14 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69530 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
168.4 |
mmHg |
7.0 |
25.24 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69540 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
126.0 |
mmHg |
4.1 |
14.78 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69528 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (20 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
20 |
serial mean |
118.9 |
mmHg |
4.4 |
19.68 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69529 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
serial mean |
141.7 |
mmHg |
7.4 |
26.68 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69536 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
111.3 |
mmHg |
4.6 |
21.08 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69541 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
serial mean |
134.7 |
mmHg |
7.4 |
22.2 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69544 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
137.4 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69545 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
serial mean |
159.0 |
mmHg |
7.1 |
21.3 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
69546 |
151 |